Aliskiren (Rasilez▼): risk of cardiovascular and renal adverse reactions

2014-12-11T14:32:50+00:00

New contraindications and warnings for combination of aliskiren (Rasilez) with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs).